» Articles » PMID: 26561650

Requirement of Clusterin Expression for Prosurvival Autophagy in Hypoxic Kidney Tubular Epithelial Cells

Overview
Specialties Nephrology
Physiology
Date 2015 Nov 13
PMID 26561650
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular autophagy is a prosurvival mechanism in the kidney against ischemia-reperfusion injury (IRI), but the molecular pathways that activate the autophagy in ischemic kidneys are not fully understood. Clusterin (CLU) is a chaperone-like protein, and its expression is associated with kidney resistance to IRI. The present study investigated the role of CLU in prosurvival autophagy in the kidney. Renal IRI was induced in mice by clamping renal pedicles at 32°C for 45 min. Hypoxia in renal tubular epithelial cell (TEC) cultures was induced by exposure to a 1% O2 atmosphere. Autophagy was determined by either light chain 3-BII expression with Western blot analysis or light chain 3-green fluorescent protein aggregation with confocal microscopy. Cell apoptosis was determined by flow cytometric analysis. The unfolded protein response was determined by PCR array. Here, we showed that autophagy was significantly activated by IRI in wild-type (WT) but not CLU-deficient kidneys. Similarly, autophagy was activated by hypoxia in human proximal TECs (HKC-8) and WT mouse primary TECs but was impaired in CLU-null TECs. Hypoxia-activated autophagy was CLU dependent and positively correlated with cell survival, and inhibition of autophagy significantly promoted cell death in both HKC-8 and mouse WT/CLU-expressing TECs but not in CLU-null TECs. Further experiments showed that CLU-dependent prosurvival autophagy was associated with activation of the unfolded protein response in hypoxic kidney cells. In conclusion, these data suggest that activation of prosurvival autophagy by hypoxia in kidney cells requires CLU expression and may be a key cytoprotective mechanism of CLU in the protection of the kidney from hypoxia/ischemia-mediated injury.

Citing Articles

Non-targeted LC-MS metabolomics reveals serum metabolites for high-altitude adaptation in Tibetan donkeys.

Wang J, Feng Y, Xu S, Tenzin N, Han H, Gong D Sci Rep. 2025; 15(1):46.

PMID: 39747337 PMC: 11696620. DOI: 10.1038/s41598-024-83544-8.


Apolipoprotein J Attenuates Vascular Restenosis by Promoting Autophagy and Inhibiting the Proliferation and Migration of Vascular Smooth Muscle Cells.

Yang N, Dong B, Song Y, Li Y, Kou L, Qin Q J Cardiovasc Transl Res. 2022; 15(5):1086-1099.

PMID: 35244876 DOI: 10.1007/s12265-022-10227-y.


Links between the unfolded protein response and the DNA damage response in hypoxia: a systematic review.

Bolland H, Ma T, Ramlee S, Ramadan K, Hammond E Biochem Soc Trans. 2021; 49(3):1251-1263.

PMID: 34003246 PMC: 8286837. DOI: 10.1042/BST20200861.


Clusterin Protects Lipotoxicity-Induced Apoptosis via Upregulation of Autophagy in Insulin-Secreting Cells.

Hong S, Lee J, Kim M, Moon S, Kwon H, Park S Endocrinol Metab (Seoul). 2020; 35(4):943-953.

PMID: 33261311 PMC: 7803614. DOI: 10.3803/EnM.2020.768.


Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer's Disease.

Krishnan S, Shrestha Y, Jayatunga D, Rea S, Martins R, Bharadwaj P Int J Mol Sci. 2020; 21(18).

PMID: 32937909 PMC: 7554997. DOI: 10.3390/ijms21186739.